<reuters><date> 1-APR-1987 15:10:52.71</date><topics /><title>GENENTECH &lt;GENE&gt; SAYS FDA TO REVIEW TPA</title><body>Genentech Inc said Activase,
its tissue plasminogen activator, will be reviewed at the a
regularly scheduled May 29 meeting of the Food and Drug
Administration's cardiorenal advisory committee.
 Reuter
</body></reuters>